SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-15-050487
Filing Date
2015-08-18
Accepted
2015-08-18 18:00:28
Documents
1
Period of Report
2015-08-17

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v418539_4.html 4  
1 OWNERSHIP DOCUMENT v418539_4.xml 4 3173
  Complete submission text file 0001144204-15-050487.txt   4844
Mailing Address 420 LEXINGTON AVENUE SUITE 350 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 350 NEW YORK NY 10170 212-584-4171
Caladrius Biosciences, Inc. (Issuer) CIK: 0000320017 (see all company filings)

IRS No.: 222343568 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8090 Services-Misc Health & Allied Services, NEC
Office of Life Sciences

Mailing Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121
Business Address
Mazzo David J (Reporting) CIK: 0001334549 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33650 | Film No.: 151062404